Case Report: Deep brain stimulation in SYNJ1-related early-onset parkinsonism
Observations support DBS as a feasible symptomatic strategy in selected genetic early-onset Parkinson’s disease (EOPD) while emphasizing genotype-specific uncertainty.
We have 2 of 8 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Observations support DBS as a feasible symptomatic strategy in selected genetic early-onset Parkinson’s disease (EOPD) while emphasizing genotype-specific uncertainty.
The AD-specific transcriptomic risk scores (TRSs) developed in this study shows promising clinical utility in AD diagnosis, differential diagnosis, and risk prediction, providing valuable translational medical evidence for early screening and precision prevention of Alzheimer's disease.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.